Insider Shareholders with Direct Ownership of Arcus Biosciences, Inc. (RCUS)
This section provides a comprehensive overview of the insiders with direct ownership of Arcus Biosciences, Inc. (RCUS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Arcus Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gilead Sciences Inc
> 10% Shareholder |
21,898,095 | 0 | 30,061,124 $391 Million | 3 |
Jan 29, 2024
Added 33.64%
|
|
Terry J Rosen
Chief Executive Officer |
481,148 | 122,989 | 2,534,360 $33 Million | 18 |
Jan 23, 2025
Added 6.11%
|
|
Column Group Ii, Lp
> 10% Shareholder |
3,540,850 | 0 | 470,427 $6.12 Million | 1 |
Mar 19, 2018
Added 50.0%
|
|
Juan C. Jaen
President |
186,425 | 63,598 | 367,220 $4.78 Million | 18 |
Jan 23, 2025
Added 11.98%
|
|
Jennifer Jarrett
Chief Operating Officer |
567,050 | 460,240 | 213,369 $2.78 Million | 37 |
Jan 23, 2025
Added 18.98%
|
|
Carolyn C. Tang
General Counsel |
126,488 | 35,949 | 137,623 $1.79 Million | 17 |
Jan 23, 2025
Added 21.19%
|
|
Ii Robert C. Goeltz
Chief Financial Officer |
120,300 | 28,862 | 97,138 $1.26 Million | 14 |
Jan 23, 2025
Added 27.58%
|
|
Dimitry Sa Nuyten
Chief Medical Officer |
104,500 | 19,996 | 87,518 $1.14 Million | 8 |
Dec 15, 2024
Reduced 8.24%
|
|
David L. Lacey
Director |
22,300 | 0 | 57,652 $750,052 | 4 |
Jun 06, 2024
Added 12.72%
|
|
Kathryn E Falberg
Director |
22,300 | 50,504 | 55,300 $719,453 | 5 |
Jun 06, 2024
Added 13.19%
|
|
Antoni Ribas
Director |
22,300 | 0 | 30,350 $394,853 | 4 |
Jun 06, 2024
Added 21.68%
|
|
Alexander Azoy
Chief Accounting Officer |
25,950 | 10,210 | 30,194 $392,823 | 11 |
Jan 23, 2025
Added 36.16%
|
|
Andrew J Perlman
Director |
26,800 | 0 | 29,325 $381,518 | 5 |
Jun 06, 2024
Added 22.27%
|
|
Patrick Machado
Director |
22,300 | 0 | 25,300 $329,153 | 4 |
Jun 06, 2024
Added 24.93%
|
|
Nicole Lambert
Director |
24,000 | 0 | 24,000 $312,240 | 4 |
Jun 06, 2024
Added 25.93%
|
|
William Grossman
Chief Medical Officer |
118,750 | 15,442 | 20,723 $269,606 | 7 |
Jun 17, 2021
Reduced 15.81%
|
|
Yasunori Kaneko
Director |
26,433 | 0 | 15,200 $197,752 | 5 |
Jun 06, 2024
Added 35.59%
|